You are here
Home >
Prospective genomically-guided identification of ‘early/evolving’ and ‘undersampled’ IDH-wildtype glioblastoma leads to improved clinical outcomes Prospective genomically-guided identification of ‘early/evolving’ and ‘undersampled’ IDH-wildtype glioblastoma leads to improved clinical outcomes
